The Ozempic Shortage Is Over

Drug shortages of popular weight loss medications like semaglutide and tirzepatide have led to a booming market for off-brand substitutes. Compounding pharmacies, allowed to manufacture versions of the drugs, have become a billion-dollar industry. However, these substitutes pose significant health risks, as they are less regulated, may contain unknown substances, and could potentially lead to overdose. Despite increased production by original manufacturers, the uncertainty of product availability continues, fueling the demand for cheaper alternatives.